The 1000 First Day of Life : Effect of Multi Micronutrients Supplementation on Pregnancy Outcomes
NCT ID: NCT06035315
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
240 participants
INTERVENTIONAL
2023-05-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability of Children
NCT04157413
Micronutrient Status During Pregnancy
NCT03272022
NutFish and Nutrient Supplementation in Pregnancy Class to Improve Maternal and Birth Outcomes
NCT02959125
Prenatal Multi-micronutrient Supplementation and Pregnancy Outcome
NCT00168688
Increasing Access to Multiple Micronutrient Supplementation - A Pilot Intervention at up to 15 Clinics in Botswana
NCT05703373
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1st cluster without giving multi micronutrients; 2nd cluster giving multi micronutrients.
Differences between cluster : Additional multi micronutrients by giving : Complete multi micronutrients, calcium, vitamin D and DHA. The additional multi micronutrients were given since 1st until 3rd trimester for interventions group. There are also additional laboratory examinations for intervention group : Vitamin D, Lipid Profile and Zinc level.
In control group : we use standard public health care micronutrients (Iron supplementation and calcium); and standard blood examinations.
Ultrasound examination was performed for both cluster since 1st until 3rd trimester.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Pregnant women examine since 8 weeks gestation are being followed until delivery; are given government micronutrients; and perform ultrasound examinations each trimester and regular laboratory examination.
No interventions assigned to this group
Interventions
Pregnant women examine since 8 weeks gestation are being followed until delivery; are given additional micronutrients (Complete multi micronutrients-Calcium-Vitamin D-DHA); and perform ultrasound examinations each trimester and additional laboratory examination (Vitamin D level-Lipid profile-Zinc)
Multiple Micronutrients during pregnancy
Pregnant women examine since 8 weeks gestation are being followed until delivery; are given additional micronutrients (Complete multi micronutrients-Calcium-Vitamin D-DHA); and perform ultrasound examinations each trimester and additional laboratory examination (Vitamin D level-Lipid profile-Zinc)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple Micronutrients during pregnancy
Pregnant women examine since 8 weeks gestation are being followed until delivery; are given additional micronutrients (Complete multi micronutrients-Calcium-Vitamin D-DHA); and perform ultrasound examinations each trimester and additional laboratory examination (Vitamin D level-Lipid profile-Zinc)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age \< 10 weeks gestation
* Agree as research participant
* Living in DKI Jakarta
Exclusion Criteria
* History of PCOS
* History of Chronic Hypertension
* History of Diabetes Mellitus
* History of Preeclampsia
* Maternal chronic disease : Cardiovascular disease; Autoimmune condition; Malignancy)
* Plan to move from Jakarta prior or during pregnancy
* History of Recurrent pregnancy loss
15 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Cipto Mangunkusumo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rima Irwinda
MD, OBGYN, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo General Hospital
Jakarta Pusat, DKI Jakarta, Indonesia
Cipto Mangunkusumo General Hospital
Jakarta, , Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-02-0259
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.